Angioplasty Balloons
Angioplasty Balloons Market Forecasts to 2030 - Global Analysis By Type (Drug Eluting Balloons, Normal Balloons, Cutting Balloons, Scoring Balloons and Other Types), Material, Indication, End User and By Geography
Years Covered |
2021-2030 |
Estimated Year Value (2023) |
US $2.5 BN |
Projected Year Value (2030) |
US $3.7 BN |
CAGR (2023 - 2030) |
5.9% |
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
Largest Market |
Asia Pacific |
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Angioplasty Balloons Market is accounted for $2.5 billion in 2023 and is expected to reach $3.7 billion by 2030 growing at a CAGR of 5.9% during the forecast period. The angioplasty balloons market has been driven in large part by the increasing prevalence of cardiovascular illnesses, including peripheral artery disease and coronary artery disease. When treating artery blockages, these balloons are essential and the safety and effectiveness of angioplasty balloons have been improved by ongoing developments in the field, including the use of drug-coated balloons (DCB), scoring balloons, and better materials.
According to the Journal of the American College of Cardiology published in February 2023, the incidence rate of atherosclerotic cardiovascular disease per 1,000 person-years was 2.60 among those with raised 10-year predicted risk, 1.87 in those with low 10-year but elevated 30-year predicted risk and 0.32 in those with low 10-year and 30-year predicted risk.
Market Dynamics:
Driver:
Increasing prevalence of cardiovascular diseases
The necessity for procedures such as angioplasty develops in tandem with the global growth in the incidence of cardiovascular illnesses. An essential part of these treatments are angioplasty balloons, which are used to unblock constricted or obstructed arteries and restore blood flow. Because more angioplasty balloons are needed by healthcare institutions and providers to meet patient demands, the market is expected to develop as a result of the growing demand for angioplasty treatments.
Restraint:
High cost
Exorbitant expenses may restrict patients' access to sophisticated or customized balloon angioplasty treatments. Market penetration may be impacted by obstacles that patients in areas with little financial resources or insufficient insurance coverage may have when trying to access these services. Problems with affordability might result in market segmentation, when patients or medical professionals choose more affordable options or conventional balloon angioplasty techniques over more advanced, costly ones.
Opportunity:
Quick adoption of advanced technologies
Innovation in angioplasty balloon design and production is stimulated by the rapid adoption of sophisticated technology. In order to produce more sophisticated and useful balloons, such as those with coatings that are drug-coated, scored, or made of unique materials and coatings, it incentivizes businesses to spend money on research and development. Businesses with a competitive edge are those who develop and successfully incorporate cutting-edge technologies into their angioplasty balloons. By providing creative solutions that meet unmet demands in the industry, these businesses would be able to take a bigger chunk of the market
Threat:
Complications associated with angioplasty
The risks of thrombosis, dissection, or artery damage related to angioplasty operations may cause medical professionals to become less confident in their use of angioplasty balloons. This might result in a more circumspect approach or lower rates of these gadgets being adopted. Moreover, complicated cases may be subject to more stringent regulatory monitoring or carry out more thorough assessments, which could cause the clearance process for novel angioplasty balloon technology to lag.
Covid-19 Impact
Many hospitals and healthcare facilities around the world delayed elective operations, including non-urgent angioplasty procedures, during the early stages of the pandemic. In order to protect resources, reduce patient exposure to the virus, and provide priority to COVID-19 patients, this was done. Patients visited hospitals and clinics less frequently because to lockdown procedures and fear of infection, which decreased the amount of cardiovascular disease diagnoses and angioplasty procedures that followed thus hampered the growth of the market.
The drug eluting balloons segment is expected to be the largest during the forecast period
The drug eluting balloons segment is estimated to have a lucrative growth, because using drug-eluting balloons is primarily intended to decrease the incidence of restenosis, which is the re-narrowing of the angioplasty-treated artery. The medication coating lessens the chance that the artery may constrict again by preventing the proliferation of cells in the arterial wall. Drug-eluting balloons have become popular and well-liked by interventional cardiologists as a viable therapeutic option, particularly in situations where stent placement may not be optimal or in narrow veins where stent deployment may be difficult.
The polyurethane segment is expected to have the highest CAGR during the forecast period
The polyurethane segment is anticipated to witness the highest CAGR growth during the forecast period, because of its elasticity and durability, polyurethane is a good material to employ in medical devices that need to be strong and flexible. Polyurethane angioplasty balloons can be designed with regulated inflation and deflation characteristics, enabling accurate artery dilatation throughout the treatment. With their unique material qualities, polyurethane angioplasty balloons remain a viable option within the larger angioplasty devices market.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the aging population, poor diets, increased obesity rates, and changes in lifestyle in the Asia Pacific region. The number of CVD cases has increased, which has raised demand for interventional cardiology treatments like angioplasty. The safety and effectiveness of medical devices are guaranteed by the various regulatory frameworks that each nation in the area has for them. In order to market their products in their different countries, manufacturers must adhere to certain restrictions.
Region with highest CAGR:
Europe is projected to have the highest CAGR over the forecast period; owing to the considerable increasing interventional cardiology equipment. Moreover, Europe was seeing an increase in the prevalence of cardiovascular disorders, which was driving demand for these devices and the constant progress in balloon composition, drug-coated balloons, and imaging technology was improving angioplasty operations' efficacy and safety. Novelties like bioresorbable scaffolds and drug-eluting balloons were becoming more popular which drives the growth of the market.
Key players in the market
Some of the key players profiled in the Angioplasty Balloons Market include Boston Scientific Corporation, Medtronic, Johnson & Johnson Services, Inc., Abbott, Cardinal Health, Terumo Medical Corporation, B. Braun Melsungen AG, ENDOCOR GmbH, BIOTRONIK, Cook, Spectranetics, C. R. Bard, Inc., AngioDynamics, Becton Dickinson, Biomerics, INFINITY Angioplasty Balloon, MicroPort Scientific Corporation, Nipro Medical Corporation., Hexacath and CTK biotech, Inc
Key Developments:
In November 2023, Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept
In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology
In September 2023, Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. The WATCHMAN FLX Pro device is built upon the proven safety and procedural performance
Types Covered:
• Drug Eluting Balloons
• Normal Balloons
• Cutting Balloons
• Scoring Balloons
• Other Types
Materials Covered:
• Polyurethane
• Silicone Urethane Co-Polymers
• Nylon
• Other Materials
Indications Covered:
• Angioplasty
• Renal Artery Angioplasty
• Peripheral Angioplasty
• Carotid Angioplasty
• Venous Angioplasty
• Coronary Angioplasty
• Other Indications
End Users Covered:
• Ambulatory Surgical Centers
• Hospitals
• Cath Labs
• Specialty Clinics
• Diagnostic Centers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Angioplasty Balloons Market, By Type
5.1 Introduction
5.2 Drug Eluting Balloons
5.3 Normal Balloons
5.4 Cutting Balloons
5.5 Scoring Balloons
5.6 Other Types
6 Global Angioplasty Balloons Market, By Material
6.1 Introduction
6.2 Polyurethane
6.3 Silicone Urethane Co-Polymers
6.4 Nylon
6.5 Other Materials
7 Global Angioplasty Balloons Market, By Indication
7.1 Introduction
7.2 Angioplasty
7.3 Renal Artery Angioplasty
7.4 Peripheral Angioplasty
7.5 Carotid Angioplasty
7.6 Venous Angioplasty
7.7 Coronary Angioplasty
7.8 Other Indications
8 Global Angioplasty Balloons Market, By End User
8.1 Introduction
8.2 Ambulatory Surgical Centers
8.3 Hospitals
8.4 Cath Labs
8.5 Specialty Clinics
8.6 Diagnostic Centers
8.7 Other End Users
9 Global Angioplasty Balloons Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Boston Scientific Corporation
11.2 Medtronic
11.3 Johnson & Johnson Services, Inc.
11.4 Abbott
11.5 Cardinal Health
11.6 Terumo Medical Corporation
11.7 B. Braun Melsungen AG
11.8 ENDOCOR GmbH
11.9 BIOTRONIK
11.10 Cook
11.11 Spectranetics
11.12 C. R. Bard, Inc.
11.13 AngioDynamics
11.14 Becton Dickinson
11.15 Biomerics
11.16 INFINITY Angioplasty Balloon
11.17 MicroPort Scientific Corporation
11.18 Nipro Medical Corporation.
11.19 Hexacath
11.20 CTK biotech, Inc
List of Tables
1 Global Angioplasty Balloons Market Outlook, By Region (2021-2030) ($MN)
2 Global Angioplasty Balloons Market Outlook, By Type (2021-2030) ($MN)
3 Global Angioplasty Balloons Market Outlook, By Drug Eluting Balloons (2021-2030) ($MN)
4 Global Angioplasty Balloons Market Outlook, By Normal Balloons (2021-2030) ($MN)
5 Global Angioplasty Balloons Market Outlook, By Cutting Balloons (2021-2030) ($MN)
6 Global Angioplasty Balloons Market Outlook, By Scoring Balloons (2021-2030) ($MN)
7 Global Angioplasty Balloons Market Outlook, By Other Types (2021-2030) ($MN)
8 Global Angioplasty Balloons Market Outlook, By Material (2021-2030) ($MN)
9 Global Angioplasty Balloons Market Outlook, By Polyurethane (2021-2030) ($MN)
10 Global Angioplasty Balloons Market Outlook, By Silicone Urethane Co-Polymers (2021-2030) ($MN)
11 Global Angioplasty Balloons Market Outlook, By Nylon (2021-2030) ($MN)
12 Global Angioplasty Balloons Market Outlook, By Other Materials (2021-2030) ($MN)
13 Global Angioplasty Balloons Market Outlook, By Indication (2021-2030) ($MN)
14 Global Angioplasty Balloons Market Outlook, By Angioplasty (2021-2030) ($MN)
15 Global Angioplasty Balloons Market Outlook, By Renal Artery Angioplasty (2021-2030) ($MN)
16 Global Angioplasty Balloons Market Outlook, By Peripheral Angioplasty (2021-2030) ($MN)
17 Global Angioplasty Balloons Market Outlook, By Carotid Angioplasty (2021-2030) ($MN)
18 Global Angioplasty Balloons Market Outlook, By Venous Angioplasty (2021-2030) ($MN)
19 Global Angioplasty Balloons Market Outlook, By Coronary Angioplasty (2021-2030) ($MN)
20 Global Angioplasty Balloons Market Outlook, By Other Indications (2021-2030) ($MN)
21 Global Angioplasty Balloons Market Outlook, By End User (2021-2030) ($MN)
22 Global Angioplasty Balloons Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
23 Global Angioplasty Balloons Market Outlook, By Hospitals (2021-2030) ($MN)
24 Global Angioplasty Balloons Market Outlook, By Cath Labs (2021-2030) ($MN)
25 Global Angioplasty Balloons Market Outlook, By Specialty Clinics (2021-2030) ($MN)
26 Global Angioplasty Balloons Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
27 Global Angioplasty Balloons Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.